Meta-analysis of cortical thickness abnormalities in medication-free patients with major depressive disorder.
Qian LiYoujin ZhaoZiqi ChenJingyi LongJing DaiXiaoqi HuangSu LuiJoaquim RaduaEduard VietaGraham J KempJohn A SweeneyFei LiQi-Yong GongPublished in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2019)
Alterations in cortical thickness have been identified in major depressive disorder (MDD), but findings have been variable and inconsistent. To date, no reliable tools have been available for the meta-analysis of surface-based morphometric (SBM) studies to effectively characterize what has been learned in previous studies, and drug treatments may have differentially impacted findings. We conducted a comprehensive meta-analysis of magnetic resonance imaging (MRI) studies that explored cortical thickness in medication-free patients with MDD, using a newly developed meta-analytic mask compatible with seed-based d mapping (SDM) meta-analytic software. We performed the meta-regression to explore the effects of demographics and clinical characteristics on variation in cortical thickness in MDD. Fifteen studies describing 529 patients and 586 healthy controls (HCs) were included. Medication-free patients with MDD, relative to HCs, showed a complex pattern of increased cortical thickness in some areas (posterior cingulate cortex, ventromedial prefrontal cortex, and anterior cingulate cortex) and decreased cortical thickness in others (gyrus rectus, orbital segment of the superior frontal gyrus, and middle temporal gyrus). Most findings in the whole sample analysis were confirmed in a meta-analysis of studies recruiting medication-naive patients. Using the new mask specifically developed for SBM studies, this SDM meta-analysis provides evidence for regional cortical thickness alterations in MDD, mainly involving increased cortical thickness in the default mode network and decreased cortical thickness in the orbitofrontal and temporal cortex.
Keyphrases
- major depressive disorder
- optical coherence tomography
- case control
- bipolar disorder
- functional connectivity
- systematic review
- magnetic resonance imaging
- end stage renal disease
- healthcare
- ejection fraction
- chronic kidney disease
- prefrontal cortex
- newly diagnosed
- adverse drug
- randomized controlled trial
- prognostic factors
- magnetic resonance
- computed tomography
- obstructive sleep apnea
- patient reported outcomes
- patient reported
- hiv infected
- antiretroviral therapy